13F filing recap · Q4 2017

What did Torray Investment Partners buy in Q4 2017?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Torray account, including accounts that belong to no fund below.

Stock value

$1.01B

Positions

108

Estimated turnover

8.8%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

AMNAmn Healthcare Services, Inc.$586.0Kreported value+11.9K shares AMZNAmazon.com Inc$462.0Kreported value+395 shares GOOGAlphabet Inc.$353.0Kreported value+337 shares HONHoneywell International Inc$242.0Kreported value+1.6K shares SBUXStarbucks Corporation$235.0Kreported value+4.1K shares ECLEcolab Inc.$201.0Kreported value+1.5K shares

Increased positions

BMRNBiomarin Pharmaceutical Inc$22.10Mreported value+19.0K shares+8.3%CSCOCisco Systems, Inc.$19.87Mreported value+26.5K shares+5.4%LLoews Corp$18.80Mreported value+44.0K shares+13.3%ENBEnbridge Inc.$18.11Mreported value+65.4K shares

Reduced positions

GOOGLAlphabet Inc.$30.14Mreported value-979 shares-3.3%SCHWSchwab Charles Corp$25.70Mreported value-39.0K shares-7.2%BACBank of America Corp$24.57Mreported value-24.2K shares-2.8%AAPLApple Inc.$24.05Mreported value-5.8K shares

Exited positions

TAT&T Inc.$11.96Mprior reported value-305.4K shares-100.0%ELVElevance Health, Inc.$7.84Mprior reported value-41.3K shares-100.0%CBMCambrex Corporation$428.0Kprior reported value-7.8K shares-100.0%